Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence.
暂无分享,去创建一个
[1] Lindsay S. Keir. Shiga toxin associated hemolytic uremic syndrome. , 2015, Hematology/oncology clinics of North America.
[2] Surveillance Protocol. Shiga toxin-producing Escherichia coli (STEC) , 2015 .
[3] L. Siegfried,et al. [Cytolethal distending toxins]. , 2014, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.
[4] Christine A. Pellino. Characterization of Shiga Toxin Potency and Assembly , 2014 .
[5] A. Mellmann,et al. Enterohemorrhagic Escherichia coli Hemolysin Employs Outer Membrane Vesicles to Target Mitochondria and Cause Endothelial and Epithelial Apoptosis , 2013, PLoS pathogens.
[6] M. Fischer,et al. Prevalence of Hemolysin Genes and Comparison of ehxA Subtype Patterns in Shiga Toxin-Producing Escherichia coli (STEC) and Non-STEC Strains from Clinical, Food, and Animal Sources , 2013, Applied and Environmental Microbiology.
[7] T. J. Wiles,et al. The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives. , 2013, Future microbiology.
[8] Hui Sun,et al. Enterohemorrhagic Escherichia coli Specific Enterohemolysin Induced IL-1β in Human Macrophages and EHEC-Induced IL-1β Required Activation of NLRP3 Inflammasome , 2012, PloS one.
[9] P. Fratamico,et al. DNA sequence and analysis of a 90.1-kb plasmid in Shiga toxin-producing Escherichia coli (STEC) O145:NM 83-75. , 2012, Plasmid.
[10] J. Terajima,et al. Coordinate Control of the Locus of Enterocyte Effacement and Enterohemolysin Genes by Multiple Common Virulence Regulators in Enterohemorrhagic Escherichia coli , 2011, Infection and Immunity.
[11] H. Karch,et al. Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPα , 2011, Environmental microbiology.
[12] P. Fratamico,et al. The complete DNA sequence and analysis of the virulence plasmid and of five additional plasmids carried by Shiga toxin-producing Escherichia coli O26:H11 strain H30. , 2011, International journal of medical microbiology : IJMM.
[13] Patrik Langehanenberg,et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.
[14] T. Obrig. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease , 2010, Toxins.
[15] I. Linhartova,et al. RTX proteins: a highly diverse family secreted by a common mechanism , 2010, FEMS microbiology reviews.
[16] M. Kuehn,et al. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. , 2010, Annual review of microbiology.
[17] S. Johnson,et al. Pathophysiology of typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[18] C. Czuprynski,et al. N‐terminal region of Mannheimia haemolytica leukotoxin serves as a mitochondrial targeting signal in mammalian cells , 2010, Cellular microbiology.
[19] K. Irino,et al. Set of virulence genes and genetic relatedness of O113 : H21 Escherichia coli strains isolated from the animal reservoir and human infections in Brazil. , 2010, Journal of medical microbiology.
[20] M. Morigi,et al. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.
[21] T. Whittam,et al. Increased Adherence and Expression of Virulence Genes in a Lineage of Escherichia coli O157:H7 Commonly Associated with Human Infections , 2010, PloS one.
[22] M. Kuehn,et al. Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.
[23] B. Kemper,et al. Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli , 2009, Thrombosis and Haemostasis.
[24] M. Scott,et al. Histone-like nucleoid-structuring protein represses transcription of the ehx operon carried by locus of enterocyte effacement-negative Shiga toxin-expressing Escherichia coli. , 2009, Microbial pathogenesis.
[25] M. Morais,et al. Evidence of Pathogenic Subgroups among Atypical Enteropathogenic Escherichia coli Strains , 2009, Journal of Clinical Microbiology.
[26] A. Fruth,et al. Molecular Analysis of Virulence Profiles and Shiga Toxin Genes in Food-Borne Shiga Toxin-Producing Escherichia coli , 2009, Applied and Environmental Microbiology.
[27] L. Bakas,et al. Relevance of Fatty Acid Covalently Bound to Escherichia coli α-Hemolysin and Membrane Microdomains in the Oligomerization Process* , 2009, The Journal of Biological Chemistry.
[28] T. Whittam,et al. Characterisation of atypical enteropathogenic E. coli strains of clinical origin , 2009, BMC Microbiology.
[29] A. Mellmann,et al. Intrahost genome alterations in enterohemorrhagic Escherichia coli. , 2009, Gastroenterology.
[30] A. Mellmann,et al. Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.
[31] H. Karch,et al. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin , 2009, Molecular microbiology.
[32] T. Whittam,et al. Shiga Toxin–producing Escherichia coli Strains Negative for Locus of Enterocyte Effacement , 2009, Emerging Infectious Diseases.
[33] J. Gillespie,et al. RpoS, H-NS, and DsrA influence EHEC hemolysin operon (ehxCABD) transcription in Escherichia coli O157:H7 strain EDL933. , 2008, FEMS microbiology letters.
[34] A. Mellmann,et al. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Terajima,et al. Transcription of the ehx Enterohemolysin Gene Is Positively Regulated by GrlA, a Global Regulator Encoded within the Locus of Enterocyte Effacement in Enterohemorrhagic Escherichia coli , 2008, Journal of bacteriology.
[36] T. Besser,et al. Associations between bovine, human, and raw milk, and beef isolates of non-O157 Shiga toxigenic Escherichia coli within a restricted geographic area of the United States. , 2008, Journal of food protection.
[37] A. Mellmann,et al. Analysis of Collection of Hemolytic Uremic Syndrome- Enterohemorrhagic Escherichia coli , 2008 .
[38] A. Mellmann,et al. Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm? , 2007, PloS one.
[39] G. Attwood,et al. Molecular Subtyping and Genetic Analysis of the Enterohemolysin Gene (ehxA) from Shiga Toxin-Producing Escherichia coli and Atypical Enteropathogenic E. coli , 2007, Applied and Environmental Microbiology.
[40] A. Mellmann,et al. Subtypes of the Plasmid-Encoded Serine Protease EspP in Shiga Toxin-Producing Escherichia coli: Distribution, Secretion, and Proteolytic Activity , 2007, Applied and Environmental Microbiology.
[41] H. Karch,et al. Identification of Unconventional Intestinal Pathogenic Escherichia coli Isolates Expressing Intermediate Virulence Factor Profiles by Using a Novel Single-Step Multiplex PCR , 2007, Applied and Environmental Microbiology.
[42] A. Friedrich,et al. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. , 2007, Microbes and infection.
[43] A. Mellmann,et al. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. , 2007, International journal of medical microbiology : IJMM.
[44] H. Karch,et al. Complete sequence of the large virulence plasmid pSFO157 of the sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H- strain 3072/96. , 2006, International journal of medical microbiology : IJMM.
[45] L. Beutin,et al. Dissemination and persistence of Shiga toxin-producing Escherichia coli (STEC) strains on French dairy farms. , 2006, Veterinary microbiology.
[46] J. Harel,et al. Identification of Virulence Genes Linked with Diarrhea Due to Atypical Enteropathogenic Escherichia coli by DNA Microarray Analysis and PCR , 2006, Journal of Clinical Microbiology.
[47] A. Siitonen,et al. Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H- human isolates from Finland. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[48] T. Besser,et al. Expression of Putative Virulence Factors of Escherichia coli O157:H7 Differs in Bovine and Human Infections , 2006, Infection and Immunity.
[49] A. Friedrich,et al. Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.
[50] A. Friedrich,et al. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. , 2006, Seminars in thrombosis and hemostasis.
[51] S. Wai,et al. Release of the type I secreted α‐haemolysin via outer membrane vesicles from Escherichia coli , 2006 .
[52] B. Finlay,et al. A Positive Regulatory Loop Controls Expression of the Locus of Enterocyte Effacement-Encoded Regulators Ler and GrlA , 2005, Journal of bacteriology.
[53] H. Karch,et al. Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.
[54] A. Mellmann,et al. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] C. Czuprynski,et al. Mannheimia haemolytica Leukotoxin Induces Apoptosis of Bovine Lymphoblastoid Cells (BL-3) via a Caspase-9-Dependent Mitochondrial Pathway , 2005, Infection and Immunity.
[56] H. Karch,et al. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.
[57] P. Tarr,et al. Shiga-toxin-producing and haemolytic uraemic syndrome , 2005 .
[58] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[59] M. Blanco,et al. Phenotypic and genotypic characteristics of non-O157 Shiga toxin-producing Escherichia coli (STEC) from Swiss cattle. , 2005, Veterinary microbiology.
[60] H. Karch,et al. Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.
[61] Lutz Schmitt,et al. Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (Review) , 2005, Molecular membrane biology.
[62] P. Srimanote,et al. A New Family of Potent AB5 Cytotoxins Produced by Shiga Toxigenic Escherichia coli , 2004, The Journal of experimental medicine.
[63] C. Dorman. H-NS: a universal regulator for a dynamic genome , 2004, Nature Reviews Microbiology.
[64] L. Beutin,et al. Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period , 2004, Journal of Clinical Microbiology.
[65] H. Karch,et al. Phenotypic and Genotypic Analyses of Enterohemorrhagic Escherichia coli O145 Strains from Patients in Germany , 2004, Journal of Clinical Microbiology.
[66] M. Karmali. Infection by shiga toxin-producing Escherichia coli , 2004, Molecular biotechnology.
[67] W. Goebel,et al. Oligomerization of Escherichia coli haemolysin (HlyA) is involved in pore formation , 1993, Molecular and General Genetics MGG.
[68] W. Goebel,et al. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes , 1988, Molecular and General Genetics MGG.
[69] Denisse L. Leyton,et al. Transfer Region of pO113 from Enterohemorrhagic Escherichia coli: Similarity with R64 and Identification of a Novel Plasmid-Encoded Autotransporter, EpeA , 2003, Infection and Immunity.
[70] F. Goñi,et al. Asp‐863 is a key residue for calcium‐dependent activity of Escherichia coli RTX toxin α‐haemolysin , 2003, FEBS letters.
[71] A. Friedrich,et al. Shiga Toxin 1c-Producing Escherichia coli Strains: Phenotypic and Genetic Characterization and Association with Human Disease , 2003, Journal of Clinical Microbiology.
[72] I. Chinen,et al. Serotypes and Shiga toxin genotypes among Escherichia coli isolated from animals and food in Argentina and Brazil. , 2003, Veterinary microbiology.
[73] M. Scott,et al. Mutations in hns reduce the adherence of Shiga toxin-producing E. coli 091:H21 strain B2F1 to human colonic epithelial cells and increase the production of hemolysin. , 2003, Microbial pathogenesis.
[74] Tetsuya Hayashi,et al. Escherichia coli , 1983, CABI Compendium.
[75] A. Aperia,et al. Dual effects of Escherichia coliα-hemolysin on rat renal proximal tubule cells , 2002 .
[76] C. Gualerzi,et al. Temperature- and H-NS-Dependent Regulation of a Plasmid-Encoded Virulence Operon Expressing Escherichia coli Hemolysin , 2002, Journal of bacteriology.
[77] R. Hengge-aronis,et al. Signal Transduction and Regulatory Mechanisms Involved in Control of the σS (RpoS) Subunit of RNA Polymerase , 2002, Microbiology and Molecular Biology Reviews.
[78] Tatsuo Yamamoto,et al. Enterohemolysin operon of Shiga toxin‐producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes , 2002, FEBS letters.
[79] F. Goñi,et al. His-859 Is an Essential Residue for the Activity and pH Dependence of Escherichia coli RTX Toxin α-Hemolysin* , 2002, The Journal of Biological Chemistry.
[80] L. Trabulsi,et al. 10.321/eid0805.Typical and Atypical Enteropathogenic Escherichia coli , 2002, Emerging infectious diseases.
[81] Jianguo Xu,et al. [Serological investigations on patients with hemolytic uremic syndromes due to enterohemorrhagic Escherichia coli O157:H7 infection]. , 2002, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[82] P. Kuhnert,et al. RTX toxins in Pasteurellaceae. , 2002, International journal of medical microbiology : IJMM.
[83] L. Beutin,et al. The bacteriophage-associated ehly1 and ehly2 determinants from Escherichia coli O26:H- strains do not encode enterohemolysins per se but cause release of the ClyA cytolysin. , 2002, International journal of medical microbiology : IJMM.
[84] P. Srimanote,et al. Characterization of Saa, a Novel Autoagglutinating Adhesin Produced by Locus of Enterocyte Effacement-Negative Shiga-ToxigenicEscherichia coli Strains That Are Virulent for Humans , 2001, Infection and Immunity.
[85] Getting ADC to paediatricians in developing countries , 2001, Archives of disease in childhood.
[86] S. Djordjevic,et al. The detection of Shiga toxin-producing Escherichia coli in diagnostic bovine faecal samples using vancomycin-cefixime-cefsulodin blood agar and PCR. , 2001, FEMS microbiology letters.
[87] S. Bhakdi,et al. Interaction of Escherichia coli hemolysin with biological membranes. A study using cysteine scanning mutagenesis. , 2001, European journal of biochemistry.
[88] L. Trabulsi,et al. 10.321/eid0805.Typical and Atypical Enteropathogenic Escherichia coli , 2002, Emerging infectious diseases.
[89] R. Welch,et al. RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. , 2001, Current topics in microbiology and immunology.
[90] J. Samuel,et al. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. , 1999, The Journal of infectious diseases.
[91] J. Lanser,et al. Molecular Characterization of a Shiga ToxigenicEscherichia coli O113:H21 Strain Lacking eaeResponsible for a Cluster of Cases of Hemolytic-Uremic Syndrome , 1999, Journal of Clinical Microbiology.
[92] R B Hill,et al. The interaction between RTX toxins and target cells. , 1999, Trends in microbiology.
[93] T. Beveridge. Structures of Gram-Negative Cell Walls and Their Derived Membrane Vesicles , 1999, Journal of bacteriology.
[94] S. McEwen,et al. Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.
[95] H. Karch,et al. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. , 1999, The Journal of infectious diseases.
[96] Jian Fei Wang,et al. Actinobacillus actinomycetemcomitansLeukotoxin Induces Apoptosis in HL-60 Cells , 1998, Infection and Immunity.
[97] Guy Plunkett,et al. The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. , 1998, Nucleic acids research.
[98] J. Colbourne,et al. Evolution of Enterohemorrhagic Escherichia coli Hemolysin Plasmids and the Locus for Enterocyte Effacement in Shiga Toxin-Producing E. coli , 1998, Infection and Immunity.
[99] P. Stanley,et al. Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function , 1998, Microbiology and Molecular Biology Reviews.
[100] Jian Fei Wang,et al. RTX Toxins Recognize a β2 Integrin on the Surface of Human Target Cells* , 1997, The Journal of Biological Chemistry.
[101] F. D. Del Castillo,et al. The Escherichia coli K‐12 sheA gene encodes a 34‐kDa secreted haemolysin , 1997, Molecular microbiology.
[102] Y. Takeda. Enterohaemorrhagic Escherichia coli. , 1997, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[103] R. Welch,et al. Association of RTX toxins with erythrocytes , 1996, Infection and immunity.
[104] H. Karch,et al. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome , 1996, Journal of clinical microbiology.
[105] R. Benz,et al. Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. , 1996, European journal of biochemistry.
[106] H. Karch,et al. Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:h7. , 1996, Microbiology.
[107] R. Welch,et al. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7 , 1996, Infection and immunity.
[108] R. Welch,et al. Biological effects of RTX toxins: the possible role of lipopolysaccharide. , 1995, Trends in microbiology.
[109] R. Welch,et al. Battling against host phagocytes: the wherefore of the RTX family of toxins? , 1995, Infectious agents and disease.
[110] S. Gottesman,et al. A small RNA acts as an antisilencer of the H-NS-silenced rcsA gene of Escherichia coli. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[111] L. Beutin,et al. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.
[112] P. Stanley,et al. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. , 1994, Science.
[113] L. Beutin,et al. The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. , 1994, FEMS microbiology letters.
[114] L. Beutin,et al. Characterization and sequence of a 33-kDa enterohemolysin (Ehly 1)-associated protein in Escherichia coli. , 1993, Gene.
[115] L. Beutin,et al. Isolation of enterohemolysin (Ehly2)-associated sequences encoded on temperate phages of Escherichia coli. , 1993, Gene.
[116] V. V. van Hinsbergh,et al. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. , 1992, Blood.
[117] J. Issartel,et al. Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation , 1991, Nature.
[118] M. Ozel,et al. Enterohemolysin production is associated with a temperate bacteriophage in Escherichia coli serogroup O26 strains , 1990, Journal of bacteriology.
[119] W. Seeger,et al. Effects of Escherichia coli hemolysin on endothelial cell function , 1990, Infection and immunity.
[120] S. Bhakdi,et al. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. , 1990, The Journal of clinical investigation.
[121] L. Beutin,et al. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli , 1989, Journal of clinical microbiology.
[122] S. Bhakdi,et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes , 1989, The Journal of experimental medicine.
[123] L. Becker,et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.
[124] R. Welch,et al. Transcriptional organization of the Escherichia coli hemolysin genes , 1988, Journal of bacteriology.
[125] L. Beutin,et al. Enterohemolysin, a new type of hemolysin produced by some strains of enteropathogenic E. coli (EPEC). , 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.
[126] N. Mackman,et al. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores , 1986, Infection and immunity.
[127] W. Goebel,et al. Transport of hemolysin across the outer membrane of Escherichia coli requires two functions , 1983, Journal of bacteriology.
[128] W. Goebel,et al. Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli , 1982, Journal of bacteriology.
[129] W. Kunicki-Goldfinger,et al. [Escherichia coli hemolysins]. , 1955, Acta microbiologica Polonica.